The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions

Aug.22.2025
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
On August 22, the U.S. FDA issued two notices soliciting public comments on regulations regarding tobacco retailer training programs and restrictions on tobacco sales. Both notices provide a 60-day public comment period under the Paperwork Reduction Act, aiming to protect public health, especially that of children and adolescents, by regulating retailer behavior and restricting tobacco sales.

Key points: 

·Tobacco retailer training program: The FDA plans to establish standards to regulate tobacco retailer training programs, covering topics such as federal laws restricting the sale, advertising, and promotion of tobacco products. It is estimated that approximately 239,100 tobacco retailers will need to develop training programs that conform to the guidelines. 

·Regulations on tobacco sales: These regulations aim to protect children and adolescents by restricting the sale and distribution of cigarettes and smokeless tobacco. Tobacco product manufacturers, distributors, and retailers are required to notify the FDA at least 30 days before using any advertising or labeling media not listed in the regulations. 

·Public comment period: Both notices provide a 60-day public comment period, during which the public can submit feedback electronically or in writing.

 


 

According to the FDA website's announcement on August 22nd, the U.S. FDA has issued two notifications in the Federal Register, one regarding tobacco retailer training programs and the other seeking public input on regulations limiting tobacco sales.

 

Tobacco Retailer Training Program (Docket No. FDA-2025-N-2653)

 

The FDA is considering establishing standards to regulate tobacco retailer training programs. These programs should cover federal laws regarding the sale, advertising, and promotion of tobacco products, the health and economic impacts of tobacco use, and policies prohibiting sales to minors. The FDA estimates that around 239,100 tobacco retailers will need to develop training programs that comply with these guidelines. The program will also include requirements such as written tests, annual training updates, and record-keeping. The FDA projects that the annual burden of developing training programs, establishing written policies, and conducting internal compliance checks for information collection activities will be 1,992,500 hours, with a record-keeping burden of 191,280 hours.

 

Regulations restricting tobacco sales (Docket No. FDA-2025-N-2652)

 

The regulation aims to protect children and adolescents by restricting the sale and distribution of both traditional and smokeless tobacco products. It requires tobacco product manufacturers, distributors, and retailers to notify the FDA at least 30 days before using any advertising or labeling medium not specifically listed in the regulation. The FDA anticipates approximately four respondents to submit alternative advertising notifications each year, with an average burden of 1 hour per notification. Since 2022, the FDA has received a total of 12 such notifications.

 

Public Opinion Consultation

 

Both notices are in accordance with the Paperwork Reduction Act of 1995, which requires a 60-day period for public comment. The public can submit electronic comments through the Federal eRulemaking Portal website, or submit written comments through mail, hand delivery, or courier. For comments containing confidential information, two copies must be submitted - one with the confidential information included, and the other with the confidential information removed for public viewing. The FDA will assess and adjust information collection activities based on public feedback.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
The UK government plans to expand police and trading standards powers by extending closure orders for shops selling illegal vapes and cigarettes from a maximum of six months to 12 months, in a crackdown on organised crime on high streets.
Jun.12
  South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea’s cigarette tax debate has resurfaced after the Ministry of Health and Welfare said tobacco price policy needed review, with a poll showing 63% of respondents support higher tobacco taxes.
Regulations
Jun.22
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12